Overview
Peter Ratcliffe practices in London, United Kingdom. Mr. Ratcliffe is rated as an Elite expert by MediFind in the treatment of Cerebral Hypoxia. His top areas of expertise are Cerebral Hypoxia, Renal Cell Carcinoma (RCC), Von Hippel-Lindau (VHL) Syndrome, and Microcephaly Deafness Syndrome.
His clinical research consists of co-authoring 118 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 43 articles in the study of Cerebral Hypoxia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Cerebral HypoxiaMr. Ratcliffe isElite. Learn about Cerebral Hypoxia.
- Advanced
- Renal Cell Carcinoma (RCC)Mr. Ratcliffe isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Experienced
- Breast CancerMr. Ratcliffe isExperienced. Learn about Breast Cancer.
- Microcephaly Deafness SyndromeMr. Ratcliffe isExperienced. Learn about Microcephaly Deafness Syndrome.
- Neuroendocrine TumorMr. Ratcliffe isExperienced. Learn about Neuroendocrine Tumor.
- PheochromocytomaMr. Ratcliffe isExperienced. Learn about Pheochromocytoma.
- Von Hippel-Lindau (VHL) SyndromeMr. Ratcliffe isExperienced. Learn about Von Hippel-Lindau (VHL) Syndrome.